Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P.
J Clin Oncol. 2003 Jun 1;21(11):2115-22. Review.PMID: 12775737 [PubMed - indexed for MEDLINE]Related articles